The latest price target for Stoneridge (NYSE:SRI) was reported by Stephens & Co. on July 8, 2024. The analyst firm set a price target for $0.00 expecting SRI to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Stoneridge (NYSE:SRI) was provided by Stephens & Co., and Stoneridge initiated their overweight rating.

The last upgrade for Stoneridge Inc happened on August 3, 2023 when Barrington Research raised their price target to N/A. Barrington Research previously had a market perform for Stoneridge Inc.

There is no last downgrade for Stoneridge.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Stoneridge, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Stoneridge was filed on July 8, 2024 so you should expect the next rating to be made available sometime around July 8, 2025.

While ratings are subjective and will change, the latest Stoneridge (SRI) rating was a initiated with a price target of $0.00 to $0.00. The current price Stoneridge (SRI) is trading at is $12.11, which is out of the analyst’s predicted range.